͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Forwarded this email? Subscribe here for more

Bitcoin: Caught in the Macro Risk Current

Macro Risk Is In Full Swing For Bitcoin

Ecoinometrics

Mar 3

∙

Preview

READ IN APP

The past seven days have been quite the roller coaster for Bitcoin's price.

Bitcoin dropped from $96,000 a week ago to $78,000 by Friday, before rebounding above $90,000. But this quick recovery doesn't necessarily mean Bitcoin is ready to build a solid base for a push to $150,000.

The reality is more complex. The same risk factors affecting all risk assets could weigh on Bitcoin for months to come.

Let's analyze the situation.

The Ecoinometrics newsletter gives you insights from crypto and macro data to help you make better investment decisions.

We spend hours every day gathering data, creating metrics and bringing them to life with data visualizations that allow you to quickly get to the heart of things.

We then distill all that knowledge in each issue of the newsletter with less words and more charts so that you get insights, direct to the point, in five minutes or less.

Join more than 30,000 investors here:

Done? Thanks! That’s great! Now let’s dive in.

Bitcoin: Caught in the Macro Risk Current

The Takeaway

Bitcoin and the NASDAQ 100 are experiencing a significant drawdown, highlighting their strong correlation through macro risk factors. While Bitcoin has rebounded from $78,000, historical patterns suggest a two to four month recovery phase.

The asset has entered a neutral consolidation regime, but multiple US-centered risks currently outweigh potential tailwinds. Bitcoin's near-term trajectory remains heavily dependent on the broader risk asset environment, making this a time for patient position building rather than leveraged exposure.